Practice Issues: Genetic test predicts tamoxifen response Paroxetine cuts tamoxifen effectiveness in breast cancerOntario study links the drug combo with increased mortality Prostate biopsy complication rate rising Canadian data reveal most hospital admissions for these adverse events are due to infections Antibody shows promise against bone tumour Trial drug overcomes resistant chronic myeloid leukemia Omacetaxine battles genetic mutation that negates existing therapy Wait times for diagnosis exceed accepted targets Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Chemo- trastuzumab combo ups survival First Previous 72 73 74 75 76 Next Last
